Skip to main content
Clinical Trials/NCT07618468
NCT07618468CompletedNot Applicable

A Single-center Clinical Study of the Efficacy and Safety of the Medical Device "Algeness Subdermal Implant Based on Agarose (Ghimas SpA/Ghimas SpA, Italy) in the Correction of Skin Contour Defects.

Estelab Clinic1 site in 1 country40 target enrollmentStarted: June 8, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
40
Locations
1

Study Overview

Brief Summary

A single-center clinical study of the efficacy and safety of the medical device "Algeness subdermal implant based on agarose (Ghimas SpA/Ghimas SpA, Italy) in the correction of skin contour defects.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age between 30 and 65 years inclusive
  • Presence of signs of age-related facial skin changes (decreased turgor, elasticity, fine wrinkles, contour defects)
  • Signed informed voluntary consent
  • Willingness and ability to comply with study procedures and attend all scheduled visits

Exclusion Criteria

  • Age under 18 years
  • Individual intolerance or allergy to any component of the investigational device
  • Diagnosed tendency to keloid or hypertrophic scarring
  • Severe chronic diseases in the acute phase
  • Acute forms of dermatological diseases
  • Coagulation disorders
  • Treatment with medications affecting blood coagulation
  • Inflammatory or infectious processes in the injection zones
  • Diagnosed autoimmune pathologies
  • Pregnancy and lactation period
  • Filler injections in the same area within the past 12 months
  • Laser procedures or chemical peels within the past 3 months
  • Oncological diseases in history or at the time of inclusion
  • Participation in another clinical study within the past 3 months

Investigators

Sponsor
Estelab Clinic
Sponsor Class
Network
Responsible Party
Principal Investigator
Principal Investigator

Chebotareva Yulia Yurievna

Principal Investigator

Estelab Clinic

Study Sites (1)

Loading locations...

Similar Trials